DK0831098T3 - Mellemprodukter og fremgangsmåde til fremstilling af olanzapin - Google Patents
Mellemprodukter og fremgangsmåde til fremstilling af olanzapinInfo
- Publication number
- DK0831098T3 DK0831098T3 DK97307383T DK97307383T DK0831098T3 DK 0831098 T3 DK0831098 T3 DK 0831098T3 DK 97307383 T DK97307383 T DK 97307383T DK 97307383 T DK97307383 T DK 97307383T DK 0831098 T3 DK0831098 T3 DK 0831098T3
- Authority
- DK
- Denmark
- Prior art keywords
- olanzapine
- intermediates
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2648796P | 1996-09-23 | 1996-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0831098T3 true DK0831098T3 (da) | 2002-05-21 |
Family
ID=21832120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97307383T DK0831098T3 (da) | 1996-09-23 | 1997-09-22 | Mellemprodukter og fremgangsmåde til fremstilling af olanzapin |
Country Status (35)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004507548A (ja) * | 2000-08-31 | 2004-03-11 | ドクター・レディーズ・ラボラトリーズ・リミテッド | オランザピン水和物の調製方法、及びこれを結晶形態のオランザピンに変換する方法 |
| US6740753B2 (en) * | 2001-01-04 | 2004-05-25 | Geneva Pharmaceuticals, Inc. | Olanzapine crystal modification |
| AU2002340328A1 (en) * | 2001-10-29 | 2003-05-12 | Janet I. Cord | Olanzapine dihydrate-ii a process for its preparation and use thereof |
| JP4530664B2 (ja) | 2001-12-24 | 2010-08-25 | サン・ファーマシューティカル・インダストリーズ・リミテッド | ２−メチル−４−（４−メチル−１−ピペラジニル）−１０Ｈ−チエノ［２，３−ｂ］［１，５］ベンゾジアゼピンの結晶形Ｉ、この結晶形Ｉの製造方法、及び医薬組成物 |
| AU2003243153A1 (en) * | 2002-04-23 | 2003-11-10 | Dr. Reddy's Laboratories Limited | Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof |
| AU2003237305A1 (en) * | 2002-05-31 | 2003-12-19 | Geneva Pharmaceuticals, Inc. | Process of preparation of olanzapine form i |
| SI21270A (sl) | 2002-07-15 | 2004-02-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Kristalne oblike olanzapina in postopki za njihovo pripravo |
| US7323459B2 (en) | 2002-12-24 | 2008-01-29 | Teva Pharmaceutical Industries Ltd. | Crystal forms, methods for their preparation and method for preparation of olanzapine |
| JP2007511605A (ja) * | 2003-11-18 | 2007-05-10 | スリーエム イノベイティブ プロパティズ カンパニー | オランザピン含有経皮薬物送達組成物 |
| JP2007515428A (ja) * | 2003-12-22 | 2007-06-14 | テバ ファーマシューティカル インダストリーズ リミティド | オランザピンの合成方法 |
| WO2005070938A1 (en) | 2004-01-27 | 2005-08-04 | Synthon B.V. | Stable salts of olanzapine |
| US20070072845A1 (en) * | 2004-02-19 | 2007-03-29 | Davuluri Rammohan Rao | Process for the preparation of olanzapine form 1 useful as antipsychotic drug |
| WO2006006185A1 (en) * | 2004-07-14 | 2006-01-19 | Shasun Chemicals And Drugs Limited | Improved process for making form i of olanzapine. |
| ES2253091B1 (es) | 2004-07-27 | 2007-02-01 | Inke, S.A. | Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo. |
| US7829700B2 (en) | 2004-09-06 | 2010-11-09 | Shasun Chemicals And Drugs Limited | Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine |
| KR20130030305A (ko) * | 2004-11-16 | 2013-03-26 | 엘란 파마 인터내셔널 리미티드 | 주사가능한 나노입자형 올란자핀 제형 |
| US7834176B2 (en) | 2006-01-26 | 2010-11-16 | Sandoz Ag | Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E |
| CA2591644A1 (en) * | 2007-06-14 | 2008-12-14 | Apotex Pharmachem Inc. | Novel processes to form-i of olanzapine |
| EP2486913A1 (en) | 2011-02-14 | 2012-08-15 | Labtec GmbH | Rapidly disintegrating oral film formulation for Olanzapin |
| JP6008734B2 (ja) * | 2012-12-20 | 2016-10-19 | 株式会社トクヤマ | オランザピンｉｉ型結晶の製造方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5302716A (en) * | 1986-01-16 | 1994-04-12 | Schering Corporation | Fused benzazepines |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| US5229382A (en) * | 1990-04-25 | 1993-07-20 | Lilly Industries Limited | 2-methyl-thieno-benzodiazepine |
| GB9009229D0 (en) * | 1990-04-25 | 1990-06-20 | Lilly Industries Ltd | Pharmaceutical compounds |
| EP0582368B1 (en) * | 1992-05-29 | 2001-01-24 | Eli Lilly And Company Limited | Thienobenzodiazepine derivatives for treatment of CNS disorders |
| US5550231A (en) * | 1993-06-15 | 1996-08-27 | Eli Lilly And Company | Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof |
| US5602124A (en) * | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
| EG23659A (en) * | 1995-03-24 | 2007-03-26 | Lilly Co Eli | Process and crystal forms of methyl-thieno-benzodiazepine |
| US5631250A (en) * | 1995-03-24 | 1997-05-20 | Eli Lilly And Company | Process and solvate of 2-methyl-thieno-benzodiazepine |
| EG24221A (en) * | 1995-03-24 | 2008-11-10 | Lilly Co Eli | Process for preparing olanzapine |
| US5637584A (en) * | 1995-03-24 | 1997-06-10 | Eli Lilly And Company | Solvate of olanzapine |
| IL128956A0 (en) * | 1996-09-23 | 2000-02-17 | Lilly Co Eli | Olanzapine dihydrate D |
-
1997
- 1997-09-02 ZA ZA978515A patent/ZA978515B/xx unknown
- 1997-09-18 CN CN97198137A patent/CN1122036C/zh not_active Expired - Lifetime
- 1997-09-18 BR BR9712100-2A patent/BR9712100A/pt not_active Application Discontinuation
- 1997-09-18 TR TR1999/00640T patent/TR199900640T2/xx unknown
- 1997-09-18 UA UA99031635A patent/UA59371C2/uk unknown
- 1997-09-18 NZ NZ334448A patent/NZ334448A/en not_active IP Right Cessation
- 1997-09-18 WO PCT/US1997/016499 patent/WO1998012199A1/en not_active Application Discontinuation
- 1997-09-18 JP JP10514842A patent/JP2001500877A/ja not_active Withdrawn
- 1997-09-18 ID IDW990058D patent/ID27275A/id unknown
- 1997-09-18 IL IL12896297A patent/IL128962A/xx not_active IP Right Cessation
- 1997-09-18 PL PL381479A patent/PL196068B1/pl unknown
- 1997-09-18 RS YUP-155/99A patent/RS49598B/sr unknown
- 1997-09-18 HU HU0000066A patent/HU226484B1/hu unknown
- 1997-09-18 KR KR1019997002424A patent/KR100560015B1/ko not_active Expired - Lifetime
- 1997-09-18 PL PL97332482A patent/PL194565B1/pl unknown
- 1997-09-18 EA EA199900326A patent/EA001642B1/ru not_active IP Right Cessation
- 1997-09-18 AU AU44841/97A patent/AU719441B2/en not_active Expired
- 1997-09-18 CA CA002265712A patent/CA2265712C/en not_active Expired - Lifetime
- 1997-09-18 PL PL381478A patent/PL196069B1/pl unknown
- 1997-09-18 CZ CZ0099099A patent/CZ299248B6/cs not_active IP Right Cessation
- 1997-09-19 IN IN1736CA1997 patent/IN187156B/en unknown
- 1997-09-22 AT AT97307383T patent/ATE209208T1/de active
- 1997-09-22 CO CO97055061A patent/CO4910140A1/es unknown
- 1997-09-22 PT PT97307383T patent/PT831098E/pt unknown
- 1997-09-22 DE DE69708428T patent/DE69708428T2/de not_active Expired - Lifetime
- 1997-09-22 ES ES97307383T patent/ES2166051T3/es not_active Expired - Lifetime
- 1997-09-22 SI SI9730288T patent/SI0831098T1/xx unknown
- 1997-09-22 MY MYPI97004392A patent/MY125565A/en unknown
- 1997-09-22 SV SV1997000081A patent/SV1997000081A/es not_active Application Discontinuation
- 1997-09-22 EP EP97307383A patent/EP0831098B1/en not_active Expired - Lifetime
- 1997-09-22 DK DK97307383T patent/DK0831098T3/da active
- 1997-09-23 AR ARP970104362A patent/AR013838A1/es not_active Application Discontinuation
- 1997-09-23 PE PE1997000855A patent/PE110398A1/es active IP Right Grant
- 1997-09-23 EG EG98697A patent/EG23861A/xx active
- 1997-09-23 US US08/935,884 patent/US6020487A/en not_active Expired - Lifetime
-
1998
- 1998-02-27 TW TW086113832A patent/TW470746B/zh not_active IP Right Cessation
-
1999
- 1999-03-22 NO NO19991382A patent/NO323980B1/no not_active IP Right Cessation
-
2009
- 2009-06-05 JP JP2009135901A patent/JP2009242407A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0831098T3 (da) | Mellemprodukter og fremgangsmåde til fremstilling af olanzapin | |
| DK0770615T3 (da) | Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner | |
| DK1038008T3 (da) | Fremgangsmåde til fremstilling af EGIII-lignende enzymer | |
| DK0922040T3 (da) | Fremgangsmåde til fremstilling af mellemprodukter til florfenicol | |
| DK0939749T3 (da) | Fremgangsmåde til fremstilling af benzylethere | |
| NO20012963L (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
| DK0909270T3 (da) | Fremgangsmåde til fremstilling af 2,4-dihydroxypyridin og 2,4-dihydroxy-3-nitropyridin | |
| DK0756597T3 (da) | Fremgangsmåde til fremstilling af puriner | |
| DK0912603T3 (da) | Fremgangsmåde til fremstilling af visse azacyclohexapeptider | |
| DK0970077T3 (da) | Forbedret fremgangsmåde til fremstilling af thiazolidindioner og nye thiazolidindioner | |
| DK0946514T3 (da) | Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler | |
| DK1039888T3 (da) | Fremgangsmåde til forøgelse af produktionen og forbedring af kvaliteten af sæd | |
| DK0905128T3 (da) | Fremgangsmåder og mellemprodukter egnede til fremstilling af antifolater | |
| DK0983249T3 (da) | Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater | |
| DK0864564T3 (da) | Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater | |
| ID18300A (id) | Metoda penemperan | |
| DK0648738T3 (da) | Fremgangsmåde til fremstilling af acetoacetarylamider | |
| DK1036319T3 (da) | Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf | |
| DK1012152T3 (da) | Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer | |
| DK0648748T3 (da) | Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2 | |
| DK0855379T3 (da) | Fremgangsmåde til fremstilling af benzophenonderivater | |
| DK1072589T3 (da) | Fremgangsmåde til fremstilling af lycopen og et mellemprodukt deraf | |
| DK0721929T3 (da) | Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner | |
| NO990018D0 (no) | Belegg og fremgangsmÕte for fremstilling derav | |
| DK0787729T3 (da) | Fremgangsmåde til fremstilling af imidazodiazepinderivater |